Altimmune (ALT) Other Non-Current Liabilities (2010 - 2026)
Altimmune (ALT) recorded Other Non-Current Liabilities of $5.76 million in Q2 2026, up 6.1% from $5.43 million a year earlier but down 0.9% from the prior quarter.
Powered by 
Analysis
Altimmune (ALT) Other Non-Current Liabilities (2010 - 2026) Analysis & Trends
At the end of FY2025, Altimmune reported Other Non-Current Liabilities of $5.75 million, up 7.9% from FY2024.
- Annual Other Non-Current Liabilities has a five-year compound annual growth rate of 1.3% (FY2020 to FY2025).
- Across earlier years, Other Non-Current Liabilities came in at $5.33 million in FY2024, $40,000 in FY2023 (-33.3%), $60,000 in FY2022 (-99.0%) and $6.09 million in FY2021 (+13.0%).
- Quarterly Other Non-Current Liabilities has ranged from $16,000 in Q1 2025 to $6.95 million in Q3 2021 over the past five years.
- Peak year-over-year performance for Other Non-Current Liabilities in the last five years was growth of 13.0% in Q4 2021, against a decline of 99.0% in Q4 2022 at the low end.
- Per Business Quant, the preceding three quarters came in at $5.82 million (Q1 2026), $5.75 million (Q4 2025) and $5.8 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,137.36 Bn | 1,105.95 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.62 Bn | 536.15 Bn | 17.26 Bn |
| 3 | AbbVie | 501.17 Bn | 474.28 Bn | 12.70 Bn |
| 4 | Merck | 368.13 Bn | 322.51 Bn | 12.21 Bn |
| 5 | Novartis Ag | 297.75 Bn | 261.74 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.23 Bn | 234.92 Bn | 12.86 Bn |
| 7 | Amgen | 236.68 Bn | 192.08 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 190.97 Bn | 165.17 Bn | 6.22 Bn |
| 9 | Pfizer | 169.72 Bn | 116.36 Bn | 10.94 Bn |
| 10 | Altimmune | 417.25 Mn | -724.97 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.76 Mn |
| Mar 31, 2026 | 5.82 Mn |
| Dec 31, 2025 | 5.75 Mn |
| Sep 30, 2025 | 5.80 Mn |
| Jun 30, 2025 | 5.43 Mn |
| Mar 31, 2025 | 16,000.00 |
| Dec 31, 2024 | 5.33 Mn |
| Sep 30, 2024 | 26,000.00 |
| Jun 30, 2024 | 31,000.00 |
| Mar 31, 2024 | 37,000.00 |
| Dec 31, 2023 | 40,000.00 |
| Dec 31, 2022 | 60,000.00 |
| Mar 31, 2022 | 4.31 Mn |
| Dec 31, 2021 | 6.09 Mn |
| Sep 30, 2021 | 6.95 Mn |
| Jun 30, 2021 | 5.27 Mn |
| Mar 31, 2021 | 6.27 Mn |
| Dec 31, 2020 | 5.39 Mn |
| Sep 30, 2020 | 25.07 Mn |
| Jun 30, 2020 | 16.39 Mn |
API Access
Altimmune Other Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=ALT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-liabilities", "ticker": "ALT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=ALT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();